Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
arcadiapartners.com

See what CB Insights has to offer

Investments

20

Portfolio Exits

12

Funds

1

Partners & Customers

1

About Arcadia Partners

Arcadia Partners (Arcadia) is a venture capital firm focused exclusively on the for-profit education industry. Based in Boston, Massachusetts, Arcadia was established in 1998 by Liam S. Donohue and Andrew W. Hallowell. The firm has a capital base of approximately $50 million and have completed over 19 investments.

Arcadia Partners Headquarter Location

One Washington Mall 8th Floor

Boston, Massachusetts, 02108,

United States

(617) 226-2600

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Arcadia Partners News

Arcadia Partners with Datavant to Accelerate Biopharma Research

May 4, 2022

San Francisco, California, UNITED STATES BOSTON and SAN FRANCISCO, May 04, 2022 (GLOBE NEWSWIRE) -- Arcadia, the leading data analytics platform for healthcare and life sciences, and Datavant, the leader in helping organizations securely connect health data today announced a partnership to enable de-identified connectivity of Arcadia’s electronic health record data for life sciences research and commercial analytics. Arcadia's real-world data (RWD) is built on an active EHR and claims-based patient population growing at 20% YoY with comprehensive visibility across payers, multiple sites of care, and the entire clinical patient journey. Using Datavant, life sciences and research organizations will be able to leverage Arcadia’s data for health economics and outcomes research, medical affairs, and commercial analyses. This partnership will unlock fresh insights to accelerate whole-person care, extending Arcadia’s leadership in empowering a data driven transformation of healthcare and enabling happier, healthier lives for all. Datavant will allow clients to connect Arcadia data to other types of RWD available in Datavant’s ecosystem of more than 500 partners including insurance claims, labs, imaging, social determinants, devices, and other data that describe patient health. “We are excited about working with Datavant to unlock transformative insights in life sciences research,” said Jim Robbins, SVP of Life Sciences at Arcadia. “Datavant’s privacy-compliant technology enables us to offer a growing research-ready clinical and claims data asset to advance important outcomes analyses and the ability to link our data asset to a myriad of other data sources to answer tailored research questions, all focused on advancing human health outcomes.” “Longitudinal clinical data is one of the most important emerging data sources reflecting patient’s entire health journey,” noted Travis May, Founder and President of Datavant. “We are excited to work with Arcadia to enable life sciences companies to advance their research through the privacy-compliant use of electronic health record data.” Join Arcadia at ISPOR at booth #523 to learn more about how their data can support biopharmaceutical research. Learn more at arcadia.io/rwd . About Arcadia Arcadia is dedicated to happier, healthier days for all. We transform data into powerful insights that deliver results. Through our partnerships with the nation’s leading health systems, payers, and life science companies, we are growing a community of innovation to improve care, maximize value, and confront emerging challenges. For more information, visit arcadia.io . About Datavant Datavant’s mission is to connect the world’s health data to improve patient outcomes. Datavant works to reduce the friction of data sharing across the healthcare industry by building technology that protects the privacy of patients while supporting the linkage of patient health records across datasets. Learn more about Datavant at www.datavant.com . Media Contacts:

Arcadia Partners Investments

20 Investments

Arcadia Partners has made 20 investments. Their latest investment was in Business Intelligence Advisors as part of their Series A on September 9, 2008.

CBI Logo

Arcadia Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/22/2008

Series A

Business Intelligence Advisors

$12M

Yes

2/21/2007

Unattributed VC - III

Verso Technologies

$5M

Yes

1/23/2006

Unattributed VC - II

Health Dialog Services Corporation

$170M

Yes

7/15/2004

Series B

Subscribe to see more

$99M

Subscribe to see more

0

4/11/2001

Unattributed VC - II

Subscribe to see more

$99M

Subscribe to see more

0

Date

9/22/2008

2/21/2007

1/23/2006

7/15/2004

4/11/2001

Round

Series A

Unattributed VC - III

Unattributed VC - II

Series B

Unattributed VC - II

Company

Business Intelligence Advisors

Verso Technologies

Health Dialog Services Corporation

Subscribe to see more

Subscribe to see more

Amount

$12M

$5M

$170M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

Arcadia Partners Portfolio Exits

12 Portfolio Exits

Arcadia Partners has 12 portfolio exits. Their latest portfolio exit was Lisapharma on July 01, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/1/2019

Acquired

$99M

1

11/2/2016

Acquired

$99M

1

1/5/2016

Acquired

$99M

1

10/1/2014

Acq - Fin - III

Subscribe to see more

$99M

Subscribe to see more

10

12/20/2007

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

7/1/2019

11/2/2016

1/5/2016

10/1/2014

12/20/2007

Exit

Acquired

Acquired

Acquired

Acq - Fin - III

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

0

Arcadia Partners Acquisitions

4 Acquisitions

Arcadia Partners acquired 4 companies. Their latest acquisition was Lisapharma on August 04, 2015.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

8/4/2015

$99M

Acq - Fin

1

1/13/2015

Subscribe to see more

$99M

Subscribe to see more

10

8/18/2006

Subscribe to see more

$99M

Subscribe to see more

0

1/1/2003

Subscribe to see more

$99M

Subscribe to see more

0

Date

8/4/2015

1/13/2015

8/18/2006

1/1/2003

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Total Funding

Note

Acq - Fin

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

0

0

Arcadia Partners Fund History

1 Fund History

Arcadia Partners has 1 fund, including DHM Arcadia Partners LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/15/1999

DHM Arcadia Partners LP

Multi-Stage Venture Capital

Closed

$45M

1

Closing Date

10/15/1999

Fund

DHM Arcadia Partners LP

Fund Type

Multi-Stage Venture Capital

Status

Closed

Amount

$45M

Sources

1

Arcadia Partners Partners & Customers

1 Partners and customers

Arcadia Partners has 1 strategic partners and customers. Arcadia Partners recently partnered with Datavant on May 5, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

5/4/2022

Partner

United States

Arcadia Partners with Datavant to Accelerate Biopharma Research

BOSTON and SAN FRANCISCO , May 04 , 2022 -- Arcadia Partners , the leading data analytics platform for healthcare and life sciences , and Datavant , the leader in helping organizations securely connect health data today announced a partnership to enable de-identified connectivity of Arcadia Partners 's electronic health record data for life sciences research and commercial analytics .

1

Date

5/4/2022

Type

Partner

Business Partner

Country

United States

News Snippet

Arcadia Partners with Datavant to Accelerate Biopharma Research

BOSTON and SAN FRANCISCO , May 04 , 2022 -- Arcadia Partners , the leading data analytics platform for healthcare and life sciences , and Datavant , the leader in helping organizations securely connect health data today announced a partnership to enable de-identified connectivity of Arcadia Partners 's electronic health record data for life sciences research and commercial analytics .

Sources

1

Arcadia Partners Team

5 Team Members

Arcadia Partners has 5 team members, including current Founding Partner, Liam Donohue.

Name

Work History

Title

Status

Andrew W. Hallowell

Industrial Capital Group Inc., and Brown Brothers Harriman

Founder

Current

Liam Donohue

Founding Partner

Current

So-June Donohue

Chief Financial Officer

Former

So June Min

Chief Financial Officer

Former

Jane Swift

General Partner

Former

Name

Andrew W. Hallowell

Liam Donohue

So-June Donohue

So June Min

Jane Swift

Work History

Industrial Capital Group Inc., and Brown Brothers Harriman

Title

Founder

Founding Partner

Chief Financial Officer

Chief Financial Officer

General Partner

Status

Current

Current

Former

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.